HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Crul Selected Research

Fatigue

11/2005Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Crul Research Topics

Disease

6Neoplasms (Cancer)
09/2017 - 03/2001
1Lymphoma (Lymphomas)
10/2018
1Febrile Neutropenia
11/2005
1Fatigue
11/2005
1Neutropenia
11/2005
1Thrombocytopenia (Thrombopenia)
11/2005
1Neoplasm Metastasis (Metastasis)
03/2004
1Carcinoma (Carcinomatosis)
06/2002
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2002

Drug/Important Bio-Agent (IBA)

3tipifarnib (R115777)IBA
11/2005 - 01/2002
2Cisplatin (Platino)FDA LinkGeneric
11/2005 - 12/2002
2Antineoplastic Agents (Antineoplastics)IBA
01/2002 - 03/2001
1Drug CombinationsIBA
10/2018
1Folic Acid AntagonistsIBA
09/2017
1Methotrexate (Mexate)FDA LinkGeneric
09/2017
1Pharmaceutical PreparationsIBA
09/2017
1GemcitabineFDA Link
11/2005
1ElectrolytesIBA
11/2005
1N- (1- (2,2- dimethyl- 1,3- dioxol- 4- yl)- 2- ((4,4- (trifluoromethoxyphenoxy)phenyl)sulfonyl)ethyl)- N- hydroxyformamideIBA
03/2004
1Matrix Metalloproteinases (MMPs)IBA
03/2004
1DNA (Deoxyribonucleic Acid)IBA
12/2002
1Proteins (Proteins, Gene)FDA Link
06/2002
1Tumor Biomarkers (Tumor Markers)IBA
06/2002
1Carcinoembryonic AntigenIBA
06/2002
1PlatinumIBA
06/2002
1TransferasesIBA
06/2002
1Codon (Codons)IBA
06/2002
1TabletsIBA
01/2002
1Capsules (Microcapsules)IBA
01/2002

Therapy/Procedure

1Drug Therapy (Chemotherapy)
10/2018
1Therapeutics
10/2018
1Oral Administration
06/2002